• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无基质血红蛋白制剂的冠状血管作用。

Coronary vascular actions of stroma-free hemoglobin preparations.

作者信息

Biro G P, Taichman G C, Lada B, Keon W J, Rosen A L, Sehgal L R

机构信息

Department of Physiology, School of Medicine, University of Ottawa, Ontario, Canada.

出版信息

Artif Organs. 1988 Feb;12(1):40-50. doi: 10.1111/j.1525-1594.1988.tb01522.x.

DOI:10.1111/j.1525-1594.1988.tb01522.x
PMID:3355384
Abstract

The left anterior descending coronary artery was cannulated in anesthetized, open-chest dogs for use as a coronary test bed to assess the coronary vascular actions of oxygenated, unmodified and pyridoxylated, partially cross-linked (polymerized), stroma-free hemoglobin solutions (SFHS). The actions of these SFHSs were assessed in this test bed, by comparison with perfusion with whole blood. Unmodified SFHS caused significant vasoconstriction, whereas pyridoxylated, partially polymerized SFHS did not do so. The existing coronary flow during perfusion with either SFHS preparation, under basal conditions, did not increase during intracoronary infusion of adenosine. Coronary flow-autoregulation was also altered during perfusion with either SFHS, because the "normal" reactive hyperemia response, observed in the control experiments, was not seen. These findings suggest that both unmodified and pyridoxylated cross-linked (70% polymers) hemoglobin preparations possess some vascular activity when tested in the canine coronary circulation.

摘要

在麻醉开胸犬身上,将冠状动脉左前降支插管,用作冠状动脉试验台,以评估含氧的、未修饰的以及经吡哆醛化、部分交联(聚合)的无基质血红蛋白溶液(SFHS)的冠状血管作用。通过与全血灌注相比较,在该试验台中评估这些SFHS的作用。未修饰的SFHS引起显著的血管收缩,而经吡哆醛化、部分聚合的SFHS则不会。在基础条件下,使用任何一种SFHS制剂灌注时的现有冠脉血流量,在冠脉内输注腺苷期间并未增加。在用任何一种SFHS灌注期间,冠脉血流自动调节也发生了改变,因为在对照实验中观察到的“正常”反应性充血反应未出现。这些发现表明,在犬冠状动脉循环中进行测试时,未修饰的和经吡哆醛化交联(70%聚合物)的血红蛋白制剂均具有一定的血管活性。

相似文献

1
Coronary vascular actions of stroma-free hemoglobin preparations.无基质血红蛋白制剂的冠状血管作用。
Artif Organs. 1988 Feb;12(1):40-50. doi: 10.1111/j.1525-1594.1988.tb01522.x.
2
Stroma-free hemoglobin solutions prepared by crystallization and ultrafiltration methods; comparison of composition and coronary vasoconstrictor potency.通过结晶和超滤法制备的无基质血红蛋白溶液;成分与冠状动脉血管收缩效力的比较。
Adv Exp Med Biol. 1990;277:225-36. doi: 10.1007/978-1-4684-8181-5_28.
3
Adenosine deaminase in stroma-free hemoglobin solution is not responsible for coronary vasoconstriction.无基质血红蛋白溶液中的腺苷脱氨酶与冠状动脉血管收缩无关。
Adv Exp Med Biol. 1989;248:365-70. doi: 10.1007/978-1-4684-5643-1_40.
4
In vivo evaluation of pyridoxalated-polymerized hemoglobin solution.
Surg Gynecol Obstet. 1984 Nov;159(5):429-35.
5
Studies on blood substitutes based on hemoglobin and perfluorocarbon.基于血红蛋白和全氟碳化合物的血液替代品研究。
Biomater Artif Cells Immobilization Biotechnol. 1992;20(2-4):1013-20. doi: 10.3109/10731199209119755.
6
The effects of cross-linked hemoglobin on regional vascular conductance in dogs.交联血红蛋白对犬局部血管传导性的影响。
Anesth Analg. 1997 Aug;85(2):265-73. doi: 10.1097/00000539-199708000-00005.
7
Pyridoxalated polymerized stroma-free hemoglobin solution (SFHS-PP) as an oxygen-carrying fluid replacement for hemorrhagic shock in dogs.吡哆醛聚合无基质血红蛋白溶液(SFHS-PP)作为犬失血性休克的携氧液体替代品。
Mil Med. 1987 May;152(5):265-71.
8
Effects of hemoglobin perfusion on contractile function of the isolated ventricular septa.血红蛋白灌注对离体室间隔收缩功能的影响。
Biomater Artif Cells Artif Organs. 1988;16(1-3):331-45. doi: 10.3109/10731198809132582.
9
Nitric oxide does not mediate coronary vasodilation by isoflurane.一氧化氮不介导异氟烷引起的冠状动脉舒张。
Anesthesiology. 1994 Jul;81(1):209-20. doi: 10.1097/00000542-199407000-00027.
10
Ultra-pure polymerized bovine hemoglobin blood substitute: effects on the coronary circulation.超纯聚合牛血红蛋白血液替代品:对冠脉循环的影响。
Biomater Artif Cells Immobilization Biotechnol. 1992;20(2-4):669-72. doi: 10.3109/10731199209119699.

引用本文的文献

1
Nanomedicines: A Potential Treatment for Blood Disorder Diseases.纳米药物:血液疾病的一种潜在治疗方法。
Front Bioeng Biotechnol. 2019 Nov 28;7:369. doi: 10.3389/fbioe.2019.00369. eCollection 2019.
2
Immunogenicity of heme complexes of peptides designed to mimic the heme environment of myoglobin and hemoglobin.旨在模拟肌红蛋白和血红蛋白血红素环境的肽的血红素复合物的免疫原性。
Protein J. 2005 Jan;24(1):51-6. doi: 10.1007/s10930-004-0605-x.
3
Oxygen-binding heme complexes of peptides designed to mimic the heme environment of myoglobin and hemoglobin.
旨在模拟肌红蛋白和血红蛋白血红素环境的肽的氧结合血红素复合物。
Protein J. 2005 Jan;24(1):37-49. doi: 10.1007/s10930-004-0604-y.
4
Bovine haemoglobin is more potent than autologous red blood cells in restoring muscular tissue oxygenation after profound isovolaemic haemodilution in dogs.在犬类进行深度等容血液稀释后,牛血红蛋白在恢复肌肉组织氧合方面比自体红细胞更有效。
Can J Anaesth. 1996 Jul;43(7):714-23. doi: 10.1007/BF03017957.